GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (LSE:APTA) » Definitions » EPS (Diluted)

Aptamer Group (LSE:APTA) EPS (Diluted) : £-0.08 (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Aptamer Group EPS (Diluted)?

Aptamer Group's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was £-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.08.

Aptamer Group's EPS (Basic) for the six months ended in Dec. 2023 was £-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.08.

Aptamer Group's EPS without NRI for the six months ended in Dec. 2023 was £-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.08.

During the past 3 years, the average EPS without NRIGrowth Rate was -166.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Aptamer Group's highest 3-Year average EPS without NRI Growth Rate was -166.80% per year. The lowest was -166.80% per year. And the median was -166.80% per year.


Aptamer Group EPS (Diluted) Historical Data

The historical data trend for Aptamer Group's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Group EPS (Diluted) Chart

Aptamer Group Annual Data
Trend Mar19 Mar20 Jun22 Jun23
EPS (Diluted)
-0.01 -0.01 -0.03 -0.11

Aptamer Group Semi-Annual Data
Mar19 Mar20 Dec21 Jun22 Dec22 Jun23 Dec23
EPS (Diluted) Get a 7-Day Free Trial -0.02 -0.01 -0.04 -0.08 -0.01

Competitive Comparison of Aptamer Group's EPS (Diluted)

For the Biotechnology subindustry, Aptamer Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptamer Group's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptamer Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where Aptamer Group's PE Ratio falls into.



Aptamer Group EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Aptamer Group's Diluted EPS for the fiscal year that ended in Jun. 2023 is calculated as

Diluted EPS (A: Jun. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-7.836-0)/69.055
=-0.11

Aptamer Group's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.807-0)/359.338
=-0.01

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aptamer Group  (LSE:APTA) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Aptamer Group EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Aptamer Group's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptamer Group (LSE:APTA) Business Description

Traded in Other Exchanges
Address
Innovation Way, Windmill House, York, GBR, YO10 5BR
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.

Aptamer Group (LSE:APTA) Headlines

No Headlines